The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.

about

The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.

Item

http://www.wikidata.org/entity/Q50067454

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The Role of Next-Generation Se ...... scope to Molecular Microscope.

@en

The Role of Next-Generation Se ...... scope to Molecular Microscope.

@nl

type

Item

label

The Role of Next-Generation Se ...... scope to Molecular Microscope.

@en

The Role of Next-Generation Se ...... scope to Molecular Microscope.

@nl

prefLabel

The Role of Next-Generation Se ...... scope to Molecular Microscope.

@en

The Role of Next-Generation Se ...... scope to Molecular Microscope.

@nl

P1476

The Role of Next-Generation Se ...... scope to Molecular Microscope.

@en

P2093

Roman Groisberg

http://www.w3.org/2001/XMLSchema#string

Shreyaskumar R Patel

http://www.w3.org/2001/XMLSchema#string

Vivek Subbiah

http://www.w3.org/2001/XMLSchema#string

P2860

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

Genetic aberrations in imatinib-resistant dermatofibrosarcoma protuberans revealed by whole genome sequencing

Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy.

The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing.

Recurrent PTPRB and PLCG1 mutations in angiosarcoma.

Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures.

A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.

Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma

Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumors

P2888

s11912-017-0641-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-017-0641-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jason Roszik

Anthony P. Conley

P577

2017-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29030741

http://www.w3.org/2001/XMLSchema#string